QUIBRON-T SUMMARY
QUIBRON®-T
(Theophylline Tablets USP)
ACCUDOSE® Tablets
IMMEDIATE-RELEASE BRONCHODILATOR
Theophylline is structurally classified as a methylxanthine.
Quibron®-T is available as tablets intended for oral administration, containing 300 mg of anhydrous theophylline per tablet. Quibron®-T is an oral bronchodilator in an immediate-release formulation in the ACCUDOSE® Tablet design. With functional trisects and bisects, Quibron®-T Tablets can be accurately divided into 100-, 150-, and 200-mg segments to provide a variety of dosing increments, as required.
Theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.
|
